This company provides AI-driven solutions for workforce training and development. It leverages intelligent tutoring systems and adaptive learning platforms to deliver personalized upskilling at scale. The focus is on preparing employees for evolving job roles impacted by automation and AI integration.

This startup manufactures urban electric scooters that produce zero emissions and feature active riding stabilization, safety lighting, and GPS tracking. These scooters provide a lightweight and efficient transportation alternative for urban residents, reducing reliance on cars and minimizing traffic congestion.

Cullgen develops targeted protein degraders using proprietary E3 ligands to address diseases that currently lack effective therapies, such as certain cancers. Their technology enables the degradation of previously undruggable proteins, offering a new approach to drug discovery and development.

Drug Farm utilizes its IDInVivo⁺ platform, which employs piggyBac transposon mutagenesis for genetic screening in living animals, to identify novel drug targets for immunological diseases. By integrating this with the MedChem5 platform, which accelerates drug development through deep learning, Drug Farm advances first-in-class therapies for conditions such as hepatitis B and cancer.

<name>Hi</name> <description>Hi provides a licensed crypto‑fiat neobank platform that enables users to trade over 100 cryptocurrencies alongside traditional fiat currencies. The app combines trading, yield‑earning savings accounts, and payment functionality in a single mobile interface. Users can set flexible crypto savings goals and withdraw funds at any

IAN Intelligent Agent Network utilizes a decentralized Layer 2 infrastructure to integrate multiple AI agents, providing unbiased insights and enhancing trust through its Trust Engine, which scores Focus and Consistency. This approach addresses the issues of disinformation and bias in AI models, ensuring secure and transparent decision-making for businesses and individuals.

Immune-Onc Therapeutics develops therapeutic antibodies that target myeloid cell surface proteins to enhance the efficacy of immunotherapy for blood cancers and solid tumors. By modulating or depleting specific myeloid cell subsets, the company aims to improve treatment outcomes for the majority of cancer patients who currently do not respond to existing therapies.

Immunowake is a biotechnology company developing bi-specific antibodies that activate T-cells by utilizing a CD3 platform and a unique VEGF trap design to enhance anti-tumor responses. The company targets patients who do not respond to existing immunotherapies by overcoming tumor-induced immune suppression.

Jia provides a unified financial platform for small and medium‑size businesses in emerging markets, offering invoice, inventory, and supply‑chain financing with disbursements in under 24 hours and fees of 1‑5 %. The solution includes a no‑fee business account that earns interest on idle balances and real‑time cash‑flow tracking, all integrated via API/ERP for seamless management of capital and payments.

Lia is a sales platform providing payment solutions designed to increase conversion rates for digital schools and infoproduct sellers. The platform facilitates sales through multiple payment methods, including installment options for Pix and boleto, while offering automated risk analysis and 24/7 anti-fraud protection. Lia also manages the entire collections process to reduce partner delinquency and ensure predictable revenue streams.

Mikoptik develops digital optical equipment that integrates LED and laser light source technologies to enhance precision in imaging applications. The company addresses the need for improved light quality and efficiency in various optical systems, enabling better performance in fields such as telecommunications and medical imaging.

SyncData.ai offers an AI‑driven platform that automates the assessment, implementation, and ongoing monitoring of compliance frameworks across financial crime, cybersecurity, and industry standards such as AML, KYC, ISO, NIST, and DORA. The service identifies gaps, generates actionable remediation plans, and produces ready‑to‑use compliance documentation within minutes, reducing manual effort and accelerating audit readiness for financial institutions, fintechs, and other regulated enterprises.

Yocredito is a credit card platform in Latin America that enables users to leverage the value of their physical assets as collateral for credit. This approach addresses the lack of accessible credit options for individuals and businesses by transforming tangible assets into financial resources.

Yua connects retailers directly with manufacturers, eliminating intermediaries like wholesalers and super stockists in the glass supply chain. This approach reduces costs and improves product availability for retailers, enhancing their access to high-quality glass products.

Zhimeng is developing small molecule drugs targeting neurological diseases such as epilepsy, pain, and strokes, utilizing advanced pharmacological research methods to enhance drug efficacy and safety. The company aims to improve patient quality of life by providing effective and affordable treatment options in China and internationally.

The startup develops drugs that enhance pyroptosis, a form of programmed cell death, to trigger robust immune responses against tumors. This approach targets inflammation and tumor eradication, providing a novel therapeutic strategy for difficult-to-treat cancers.